Study List


Study List

Clinical Studies

NCT Number Gene Therapy Sponsor Status Brief Title Phase View
NCT00000320 National Institute on Drug Abuse (NIDA) COMPLETED Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1 PHASE1 View
NCT00000318 National Institute on Drug Abuse (NIDA) COMPLETED Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1 PHASE2 View
NCT00000312 National Institute on Drug Abuse (NIDA) COMPLETED Alterations in Serotonergic Functions in Cocaine Addicts - 1 PHASE1 View
NCT00000305 The University of Texas Health Science Center, Houston TERMINATED Amphetamine Cocaine Interaction Study - 2 PHASE1 View
NCT00000304 National Institute on Drug Abuse (NIDA) COMPLETED Dextroamphetamine as an Adjunct in Cocaine Treatment - 1 PHASE2 View
NCT00000303 University of California, Los Angeles COMPLETED Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6 PHASE2 View
NCT00000302 National Institute on Drug Abuse (NIDA) COMPLETED Study Comparing Liquid and Tablet Buprenorphine Formulations - 5 PHASE3 View
NCT00000295 Positive Gene Therapy National Institute on Drug Abuse (NIDA) COMPLETED Progesterone Treatment in Female Smokers - 12 PHASE2 View
NCT00000294 National Institute on Drug Abuse (NIDA) COMPLETED Effects of Carvedilol on Cocaine Use in Humans - 11 PHASE2 View
NCT00000293 National Institute on Drug Abuse (NIDA) COMPLETED Effect of Nefazodone on Relapse in Females With Cocaine Abuse - 10 PHASE3 View
NCT00000292 National Institute on Drug Abuse (NIDA) COMPLETED Acute Withdrawal From Smoked Cocaine - 9 PHASE1 View
NCT00000269 National Institute on Drug Abuse (NIDA) COMPLETED Pergolide Treatment for Substance Abusers - 4 PHASE2 View
NCT00000268 National Institute on Drug Abuse (NIDA) COMPLETED Cocaine Abuse and Attention Deficit Disorder - 3 NA View
NCT00000267 National Institute on Drug Abuse (NIDA) COMPLETED Risperidone Treatment in Dually-Diagnosed Individuals - 2 PHASE2 View
NCT00000266 National Institute on Drug Abuse (NIDA) COMPLETED Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1 PHASE2 View
NCT00000261 University of Chicago COMPLETED Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13 PHASE2 View
NCT00000260 University of Chicago COMPLETED Effects of Behavioral Contingencies on Effects of Nitrous Oxide - 12 NA View
NCT00000259 University of Chicago COMPLETED Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11 NA View
NCT00000258 University of Chicago COMPLETED Role of Instructions in Nitrous Oxide Effects and Choice - 10 NA View
NCT00000257 University of Chicago COMPLETED Effects of Alcohol History on Effects of Nitrous Oxide - 9 NA View
NCT00000256 University of Chicago COMPLETED Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8 NA View
NCT00000251 University of Chicago COMPLETED Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3 PHASE2 View
NCT00000250 University of Chicago COMPLETED Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2 PHASE2 View
NCT00000235 Positive Gene Therapy National Institute on Drug Abuse (NIDA) COMPLETED Alternate Day Buprenorphine Administration, Phase XII - 17 PHASE2 View
NCT00000234 Positive Gene Therapy University of Vermont COMPLETED Alternate Day Buprenorphine Administration, Phase XI - 16 PHASE2 View
NCT00000233 Positive Gene Therapy National Institute on Drug Abuse (NIDA) COMPLETED Alternate Day Buprenorphine Administration, Phase X - 15 PHASE2 View
NCT00000232 University of Vermont COMPLETED Alternate Day Buprenorphine Administration, Phase IX - 14 PHASE2 View
NCT00000220 National Institute on Drug Abuse (NIDA) COMPLETED Gradual Vs. Rapid Buprenorphine Detoxification - 2 PHASE1 View
NCT00000218 National Institute on Drug Abuse (NIDA) COMPLETED Pharmacotherapy and Intensive Treatment - 2 PHASE4 View
NCT00000216 Yale University COMPLETED Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1 PHASE3 View
NCT00000206 Positive Gene Therapy University of California, Los Angeles COMPLETED Clinical Rescue Protocol - 2 PHASE2 View
NCT00000205 University of California, Los Angeles COMPLETED Buprenorphine Maintenance Protocol - 1 PHASE3 View
NCT00000204 Yale University COMPLETED Buprenorphine Maintenance for Opioid Addicts - 3 PHASE2 View
NCT00000203 Yale University COMPLETED Buprenorphine Maintenance for Opioid Addicts - 2 PHASE2 View
NCT00000202 Yale University COMPLETED Buprenorphine Maintenance for Opioid Addicts - 1 PHASE2 View
NCT00000200 National Institute on Drug Abuse (NIDA) COMPLETED Cocaine Effects in Humans: Physiology and Behavior - 1 PHASE2 View
NCT00000195 Yale University WITHDRAWN Neurobiology of Opioid Dependence: 4 - 4 PHASE2 View
NCT00000194 Yale University WITHDRAWN Neurobiology of Opioid Dependence: 3 - 3 PHASE2 View
NCT00000193 Yale University WITHDRAWN Neurobiology of Opioid Dependence: 2 - 2 PHASE2 View
NCT00000192 Yale University WITHDRAWN Neurobiology of Opioid Dependence: 1 - 1 PHASE2 View
NCT00000169 National Eye Institute (NEI) UNKNOWN The Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) Study View
NCT00000168 Johns Hopkins Bloomberg School of Public Health COMPLETED Longitudinal Study of Ocular Complications of AIDS (LSOCA) View
NCT00000167 National Eye Institute (NEI) COMPLETED Complications of Age-Related Macular Degeneration Prevention Trial PHASE3 View
NCT00000161 National Eye Institute (NEI) UNKNOWN Randomized Trials of Vitamin Supplements and Eye Disease PHASE3 View
NCT00000160 Positive Gene Therapy National Eye Institute (NEI) COMPLETED Diabetic Retinopathy Study (DRS) PHASE3 View
NCT00000159 National Eye Institute (NEI) COMPLETED Sorbinil Retinopathy Trial (SRT) PHASE3 View
NCT00000158 National Eye Institute (NEI) UNKNOWN Macular Photocoagulation Study (MPS) PHASE3 View
NCT00000157 National Eye Institute (NEI) TERMINATED Randomized Trial of Aspirin and Cataracts in U.S. Physicians PHASE3 View
NCT00000156 National Eye Institute (NEI) COMPLETED The Effects of Light Reduction on Retinopathy of Prematurity (Light-ROP) PHASE3 View
NCT00000151 National Eye Institute (NEI) COMPLETED Early Treatment Diabetic Retinopathy Study (ETDRS) PHASE3 View
NCT00000150 National Eye Institute (NEI) COMPLETED Submacular Surgery Trials (SST) PHASE3 View
NCT00000135 Positive Gene Therapy Johns Hopkins Bloomberg School of Public Health COMPLETED Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT) PHASE2 View
NCT00000134 Positive Gene Therapy Johns Hopkins Bloomberg School of Public Health COMPLETED Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT) PHASE3 View
NCT00000133 National Eye Institute (NEI) COMPLETED Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) - Outcome Study of Cryotherapy for Retinopathy of Prematurity NA View
NCT00000132 National Eye Institute (NEI) UNKNOWN Early Manifest Glaucoma Trial (EMGT) PHASE3 View
NCT00000120 National Eye Institute (NEI) COMPLETED Clinical Trial of Eye Prophylaxis in the Newborn PHASE3 View
NCT00000118 National Eye Institute (NEI) COMPLETED Ganciclovir Implant Study for Cytomegalovirus Retinitis PHASE3 View
NCT00000112 National Center for Research Resources (NCRR) UNKNOWN Prevalence of Carbohydrate Intolerance in Lean and Obese Children View
NCT00000105 Positive Gene Therapy Masonic Cancer Center, University of Minnesota TERMINATED Vaccination With Tetanus and KLH to Assess Immune Responses. View
NCT00000104 National Center for Research Resources (NCRR) COMPLETED Does Lead Burden Alter Neuropsychological Development? View
NCT00000102 Positive Gene Therapy National Center for Research Resources (NCRR) COMPLETED Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets PHASE1 View